Citation: | ZENG Longbiao, LIAN Yunfei, ZHANG Jundong, TANG Wenyan, LI Juan. Progress in the industrialization of nanocrystal technology[J]. Journal of China Pharmaceutical University, 2013, 44(6): 504-510. DOI: 10.11665/j.issn.1000-5048.20130603 |
[1] |
Pardeike J,Müller RH.Nanosuspensions:a promising formulation for the new phospholipase A2 inhibitor PX-18[J].Int J Pharm,2010,391(1/2):322-329.
|
[2] |
Shegokar R,Müller RH.Nanocrystals:industrially feasible multifunctional formulation technology for poorly soluble actives[J].Int J Pharm,2010,399(1/2):129-139.
|
[3] |
Rabinow BE. Nanosuspensions in drug delivery[J]. Nat Rev Drug Discov,2004,3(9):785-796.
|
[4] |
Chaubal MV,Popescu C.Conversion of nanosuspensions into dry powders by spray drying:a case study[J].Pharm Res,2008,25(10):2 302-2 308.
|
[5] |
Beirowski J, Inghelbrecht S, Arien A, et al. Freeze-drying of nanosuspensions,1:freezing rate versus formulation design as critical factors to preserve the original particle size distribution[J].Int J Pharm,2011,100(5):1 958-1 968.
|
[6] |
Bose S,Sshenck D,Ghosh I,et al.Application of spray granulation for conversion of a nanosuspension into a dry powder form[J].Eur J Pharm Sci,2012,47(1):35-43.
|
[7] |
Müller RH,Gohla S,Keck CM.State of the art of nanocrystals-Special features,production,nanotoxicology aspects and intracellular delivery[J].Eur J Pharm Biopharm 2011,78(1):1-9.
|
[8] |
Verma S,Gokhale R,Burgess DJ.A comparative study of top-down and bottom-up approaches for the preparation of micro/nanosuspensions[J].Int J Pharm,2009,380(12):216-222.
|
[9] |
Gao L,Zhang DR,Chen MH.Drug nanocrystals for the formulation of poorly soluble drugs and its application as a potential drug delivery system[J].J Nanopart Res,2008,10(5):845-862.
|
[10] |
Peltonen L,Hirvonen J.Pharmaceutical nanocrystals by nanomilling:critical process parameters,particle fracturing and stabilization methods[J].J Pharm Pharmacol,2010,62(11):1 569-1 579.
|
[11] |
Kakran M,Shegokar R,Sahoo NG,et al.Fabrication of quercetin nanocrystals:comparison of different methods[J].Eur J Pharm Biopharm,2012,80(1):113-121.
|
[12] |
Singare DS,Marella S,Gowthamrajan K,et al.Optimization of formulation and process variable of nanosuspension:an industrial perspective[J].Int J Pharm,2010,402(1/2):213-220.
|
[13] |
Salazar J,Heinzerling O,Müller RH,et al.Process optimization of a novel production method for nanosuspensions using design of experiments(DoE)[J].Int J Pharm,2011,420(2):395-403.
|
[14] |
Keck CM,Müller RH.Drug nanocrystals of poorly soluble drugs produced by high pressure homogenisation[J].Eur J Pharm Biopharm,2006,62(1):3-16.
|
[15] |
Salazar J,Ghanem A,Müller RH,et al.Nanocrystals:comparison of the size reduction effectiveness of a novel combinative method with conventional top-down approaches[J].Eur J Pharm Biopharm,2012,81(1):82-90.
|
[16] |
Eerdenbrugh BV,Mooter GV,Augustijns P.Top-down production of drug nanocrystals:nanosuspension stabilization,miniaturization and transformation into solid products[J].Int J Pharm,2008,364(1):64-75.
|
[17] |
Wu LB,Zhang J,Watanabe W.Physical and chemical stability of drug nanoparticles[J].Adv Drug Deliv Rev,2011,63(6):456-469.
|
[18] |
Xia DN,Quan P,Piao HZ,et al.Preparation of stable nitrendipine nanosuspensions using the precipitation-ultrasonication method for enhancement of dissolution and oral bioavailability[J].Eur J Pharm Sci,2010,40(4):325-334.
|
[19] |
Merisko-Liversidge E, Liversidge G. Nanosizing for oral and parenteral drug delivery:a perspective on formulating poorly-water soluble compounds using wet media milling technology[J].Adv Drug Deliv Rev,2011,63(6):427-440.
|
[20] |
Zhang X,Sun N,Wu B,et al.Physical characterization of lansoprazole/PVP solid dispersion prepared by fluid-bed coating technique[J].Powder Technol,2008,182(3):480-485.
|
[21] |
Mishra PR,Shaal LA,Müller RH,et al.Production and characte-rization of hesperetin nanosuspensions for dermal delivery[J].Int J Pharm,2009,371(1/2):182-189.
|
[22] |
Li W,Yang YG,Tian YS,et al.Preparation and in vitro/in vivo evaluation of revaprazan hydrochloride nanosuspension[J].Int J Pharm,2011,408(1/2):157-162.
|
[23] |
Pardeike J,Strohmeier DM,Schrodl N,et al.Nanosuspensions as advanced printing ink for accurate dosing of poorly soluble drugs in personalized medicines[J].Int J Pharm,2011,420(1):93-100.
|
[24] |
Xu Y,Lu Y,Qi JP,et al.Preparation and characterization of simvastatin nanocrystal[J].China Science Paper(中国科技论文),2012,7(3):219-223.
|
[25] |
Kassem MA,Abdel Rahman AA,Ghorab MM,et al.Nanosuspension as an ophthalmic delivery system for certain glucocorticoid drugs[J].Int J Pharm,2007,340(1/2):126-133.
|
[26] |
Shaal LA,Shegokar R,Müller RH.Production and characterization of antioxidant apigenin nanocrystals as a novel UV skin protective formulation[J].Int J Pharm,2011,420(1):133-140.
|
[27] |
Li XM,Gu L,Wang YL,et al.Preparation of fenofibrate nunosuspension by melt-emulsification[J].Chin J Pharm(中国医药工业杂志),2009,40(5):349-354.
|
[28] |
Fakes MG,Vakkalagadda BJ,Qian F,et al.Enhancement of oral bioavailability of an HIV-attachment inhibitor by nanosizing and amorphous formulation approaches[J].Int J Pharm,2009,370(1/2):167-174.
|
[29] |
Gao L,Zhang DR,Chen MH,et al.Studies on pharmacokinetics and tissue distribution of oridonin nanosuspensions[J].Int J Pharm,2008,355(1/2):321-327.
|
[30] |
Ali HSM,York P,Blagden N.Preparation of hydrocortisone nanosuspension through a bottom-up nanoprecipitation technique using microfluidic reactors[J].Int J Pharm,2009,375(1/2):107-113.
|
[31] |
Xiong RL,Lu WG,Li J,et al.Preparation and characterization of intravenously injectable nimodipine nanosuspension[J].Int J Pharm,2008,350(1/2):338-343.
|
[32] |
Zheng DD,Wang YC,Zhang DR,et al.In vitro antitumor activity of silybin nanosuspension in PC-3 cells[J].Cancer Lett,2011,307(2):158-164.
|
[33] |
Teeranachaideekul V,Junyaprasert VB,Souto EB,et al.Development of ascorbyl palmitate nanocrystals applying the nanosuspension technology[J].Int J Pharm,2008,354(1/2):227-234.
|
[34] |
Wu Y,Loper A,Landis E,et al.The role of biopharmaceutics in the development of a clinical nanoparticle formulation of MK-0869:a Beagle dog model predicts improved bioavailability and diminished food effect on absorption in human[J].Int J Pharm,2004,285(1/2):135-146.
|
[35] |
Pu XH,Sun J,Li M,et al.Formulation of nanosuspensions as a new approach for the delivery of poorly soluble drugs[J].Curr Nanosci,2009,5(4):417-427.
|
[36] |
Müller RH,Keck CM.Twenty years of drug nanocrystals:where are we,and where do we go[J]?Eur J Pharm Biopharm,2012,80(1):1-3.
|
[1] | ZHANG Yilun, ZHAO Xinyi, DONG Shubo, DONG Chao, SHEN Wenbin, DONG Haijuan. Isolation and identification of unknown impurities of alogliptin benzoate[J]. Journal of China Pharmaceutical University, 2020, 51(4): 488-493. DOI: 10.11665/j.issn.1000-5048.20200415 |
[2] | ZHOU Yongmei, SHI Xianming, MA Lei, ZHANG Sifang. Isolation and identification of Withaphysalins from Physalis minima[J]. Journal of China Pharmaceutical University, 2015, 46(1): 62-65. DOI: 10.11665/j.issn.1000-5048.20150107 |
[3] | CHENG Shou-xian, WANG Rong-hua, CHEN Jie-peng, DUAN Li-li, QIU Xue-lian. Isolation,purification and identification of paclitaxel from the fermented extracts of fungus ST026(Altemaria alternate var.monosporus)[J]. Journal of China Pharmaceutical University, 2011, 42(6): 570-572. |
[4] | PENG Chen, GE Hao, HE Shu-ying, GAO Xiang-dong. Molecular cloning,expression and identification of recombinant hyaluronan synthase from Pasteurella multocida[J]. Journal of China Pharmaceutical University, 2009, 40(6): 549-552. |
[5] | Isolation and Identification of Two Taxane DiterpenoidCompounds[J]. Journal of China Pharmaceutical University, 2001, (3): 32-34. |
[6] | Research on the Identification of Herba Sedi and the other Five Species of Sedum[J]. Journal of China Pharmaceutical University, 1996, (6): 15-19. |
[7] | Investigation and Identification of Traditional Chinese Medicinal Materials Aci Pulvis[J]. Journal of China Pharmaceutical University, 1996, (1): 4-5. |
[8] | MICROSCOPIC IDENTIFICATION ON THE TISSUES OF CHINESE DRUG CHONGLOU (RHIZOMA PARIDIS)[J]. Journal of China Pharmaceutical University, 1989, (6): 330-334. |
[9] | MICROSCOPICAL IDENTIFICATION OF POWDERED ANIMAL DRUGS[J]. Journal of China Pharmaceutical University, 1985, (4): 27-34. |
[10] | Song Xuehua, Xu Guojun, Jin Rongluan, Xu Luoshan. STUDIES ON THE IDENTIFICATION OF THE CHINESE DRUGS WUJIAPI[J]. Journal of China Pharmaceutical University, 1983, (1): 15-24+80. |